All Chemistry World articles in Archive 2010-2015 – Page 156
-
NewsGlobal convention to limit mercury agreed
World signs up to treaty to ban export of mercury but sticking points remain over artisanal mining and coal power plants
-
Research
Flow synthesis for anticancer drug
A rapid, multi-step flow process has been developed to synthesise the anticancer drug Gleevec
-
BusinessIndia pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
NewsPost-publication peer review blog launches
Chemists hope forum will be a place where published synthetic methods are scrutinised and lab checks are crowdsourced
-
ResearchMopping up oil spills with marshmallows
Aerogel can suck up hydrocarbons from water, be wrung out and then reused
-
NewsCampaign to save Royal Institution's London home
Scientists and the public rally to stop the sale of the building that housed Davy’s and Faraday’s labs after charity runs into financial difficulties
-
FeatureChemical climate proxies
With the climate change debate as heated as ever, how do scientists reconstruct what the weather was like in the past? Jon Evans looks at the detective chemistry behind such environmental forensic work
-
OpinionToo many scientists?
The proliferation of PhDs is unsustainable and damaging, says Paula Stephan.
-
-
Research
Environmentally friendly alternative to toxic heavy metals in paint
Enzyme catalysts are more environmentally friendly paint drying agents than cobalt catalysts
-
Business
Vasella to leave Novartis in August
Long serving chair of the board of directors will be succeeded by Jörg Reinhardt
-
Business
OM Group to exit cobalt business
Deal worth up to $435 million includes downstream activities, in particular cobalt refining in Kokkola, Finland
-
Research
Shall I compare thee to a strand of DNA?
Cambridge scientists turn DNA into a data storage medium and use it to store all of Shakespeare's sonnets
-
-
Business
Allergan buys MAP for $958m
Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
-
Research
Reassessing the health effects of the Fukushima Daiichi nuclear accident
Scientists in the US believe the health consequences from the Japanese nuclear accident may have been underestimated
-
CareersCSIRO: a translation agency
James Mitchell Crow meets the scientists making a difference at Australia’s national science organisation
-
NewsIndian supreme court’s anger over unregulated clinical trials
Tales of collusion between drug companies and regulators leads court to criticise the government